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T.,. Fainstein-Day, P., Gdtman, R., Ferraris, J. kpartments of Pediatrics a?d Endocrinology, Italian Hospital, Fuenos Aires, Argentina. FallEe of grok+& is frequent in parlents (P) with end stage renal disease (ESRD) and after renal TX. We studied serum IFF-1 and IGFbindlng protein-3 (IGFBP-3) levels (RIA) in 18 ESRD P on dialysis 8.0-29.5 yezs old (x:18.7), and in 19 TX P 4.7-21.8 years old (x:12.9). ESRD P had lower mean IGF-1 levels (x2sd:0.66+0.25 U/ml) than TX P (1.77-0.59 U/ml, p < 3.001). In contrast, mean IGF3?-3 was higher in ZSRD P (8.022.63 ~g;l.) the? in TX P (5.?8z1.21 mg/L, p < 0.001). Mean IG?BB?3 levels in lwth poups of P (6.86i2.19 mg/L) was higher tna? in controls (n=38) (4.53t1.47 mg/L, p < 0.001). When P were divi8ed in T?rh?er I (n= ESXD:6 & TX:11) a?d Tamer IV-V stages (n= ESFB:11 & TX:8) IGF-1 and ?GF3P-3 levels were:
. . ESP& TX p < ESXD TX P < Tamer I 0.6~0.3 1.4t0.7 0.01 8.653.8 5.1t0.9 0.01 Tanner IV-V 0.7r0.2 2.3t0.9 0.001 7.621.5 6.6t1.0 NS IGF-1 levels correlated with height SDS for chronological age in ESRD (r:0.63) and in TX P (r:0.67). In TX P, there was a significant correlation between IGFBP-3 a d IGF-1 levels (r:0.53),..and between IGFBI-3 aqd Tanner stage (r :O. 56). We conclude that' increased levels of IGFBP-3 may be implicated in IGF inhibition. The physiologic elevation of IGF-1 levels during p a r t y was observed in TX P but not in ESRD P. We studied the hor.mna1 ievels of newbor~s, during the third day of life in 47 SGA infants with a mean welght of 2.29 kgs. and mem lenqth of 45.5 cms, am! in 40 controls AGA infants wirh a mean weight of 3.37 kgs. atd mean length of 49.1 cms. There were no simificaqt differences between SGA and AGA newborns In the serum corkentrations of Insulln: 4525.4 vs 4024.1 uUI/ml; Prolactin: 184238 vs 162.8t51 ng/el; T4: 13.1t3 vs 15.3~2.5 ugidl; T3: 143t47 vs 15li42 ncldl; Testosterone: 1.611.5 vs 1.2i1.1 na/ml and Estradiol: 495tt18:l vs 501t23.4 w/ml reswtivelv, but there was a significant difference in IGF-1-h?d IGF-11 levels IGF-I IGF-I1 ng/~l ng/ml P.G.9 9.1114.4 27.2t13.7 SGA 22.4t25.8 ( p < 0.001) 38.9i35.0 (p < 0.05) It is Iclcm that IGF-I 21;d to a lesser extent IGF-I1 in cord bl& aze correlated with newborn size. The higher plasma levels observed on the third day of life in SGA b.fants may signal the hgizning of covensaton whanisms of post natal growth iii these children. In a prevlous study, usmg PCR followed by restriction e.nzpe or SSCP analysis, we identified the genetic lesion in 50 % of the alleles ir the salt/losing (SL) form, but i n none of the alleles in tine simple virilizing (SV) form. In this study we have added a dotblot technique using specific oligonucleotides in order to evaluate the most frequently described mutations in American and Emopean populations. A total of 18 affected families were studied, (12 SL and 6 SV). Evaluation of hone mass in casrrated QH hes noc yet h n reporred in the li~eratlae. Our gcal was to study bone mass after the orset of ?u!!rty in a group of 19 W H raised as females, by measuring bone mineral density expressed as Z score with a Hologic QDR-1000 densitometer. Patlents were divided lnto 2 groups: Gradp I -7 patients with coinplete ( 4 cases) or partial (3 cases) a?eogen insensitivity, who had keen castrated after puberty; Group I1 -12 patients with HPH due to varlous causes, who had been castrated before puhrty, and started on estrogens either before 12 years (Group I1 A) or after 16 years , (Group I1 B) All patients In GroLr I (except for 2 cases wlth Z score of -2.16) a?d also in Group IIA had a bone mass within the normal limits. In Group IIB, all subjects had a bone mass below -2 standard deviations, (except for one case with a Z score of -0.49). We conclude that most patients with androgen insensitiviry who were castrated after puberty, and all subjects wlth various caEses of male pseudohermaphroditism who were castrated in childhood and started on estrogen before the age of 12, had normal bone mss. The preGence of endogeno~s or exogenous estrogen at the time of puberty ap-pears to be i w r t w t for the mainte~ance of normal bone mass.
